bepafant has been researched along with Shock in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, K; Förster, W; Grupe, R; Lueddeckens, G | 1 |
| Kozel, TR; Lupan, DM; Manalo, PB; Roberts, JS; Savoy, AC; Schlageter, AM; Weinhold, LC | 1 |
| Heuer, HO; Muacevic, G | 1 |
3 other study(ies) available for bepafant and Shock
| Article | Year |
|---|---|
PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Azepines; Disease Models, Animal; Diterpenes; Eicosanoids; Female; Ginkgolides; Lactones; Masoprocol; Mice; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock; Species Specificity; Triazoles | 1993 |
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis.
Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Complex; Azepines; Chlorpheniramine; Chlorpromazine; Clodronic Acid; Complement System Proteins; Cryptococcosis; Dexamethasone; Elapid Venoms; Epinephrine; Female; Immunization, Passive; Immunoglobulin Isotypes; Kidney; Liver; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Polysaccharides; Shock; Specific Pathogen-Free Organisms; Triazoles; Tumor Necrosis Factor-alpha | 1997 |
Platelet-activating factor antagonists in experimental shock.
Topics: Acid-Base Equilibrium; Animals; Azepines; Blood Pressure; Electrocardiography; Endotoxins; Hyperkalemia; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Shock; Triazoles | 1992 |